You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAF Mutation

Showing 1 - 25 of 3,067
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Brain Tumor, Primary Trial in Jinan (HLX208)

Recruiting
  • Brain Tumor, Primary
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong first medical University
May 1, 2022

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

Not yet recruiting
  • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
  • Non-investigational
  • (no location specified)
May 11, 2023

Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

Available
  • Melanoma
  • Adjuvant
  • Dabrafenib and Trametinib
  • +2 more
  • (no location specified)
Mar 1, 2022

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

Non Small Cell Lung Cancer Trial (HLX208+HLX10)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • HLX208+HLX10
  • (no location specified)
Nov 30, 2022

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • BRAF V600 Mutation
    • Lyon, Rhône Alpes, France
      CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
    Sep 14, 2022

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    BRAF V600-mutated Lung Carcinoma Treated With Combination of

    Completed
    • Non Small Cell Lung Cancer
    • BRAF V600 Mutation
      • Créteil, France
      • +1 more
      Jun 29, 2022

      Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

      Recruiting
      • Metastatic Colorectal Cancer
      • mCRC
      • Shenyang, Liaoning, China
        Liaoning Cancer Hospital
      May 1, 2022

      Metastatic Melanoma, BRAF Gene Mutation Trial in Lexington (Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg)

      Recruiting
      • Metastatic Melanoma
      • BRAF Gene Mutation
      • Nilotinib 100mg
      • +5 more
      • Lexington, Kentucky
        Markey Cancer Center
      Jul 22, 2022

      Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

      Not yet recruiting
      • Colorectal Cancer
      • +4 more
      • (no location specified)
      Aug 18, 2022

      Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

      Recruiting
      • Anaplastic Thyroid Cancer
      • +3 more
      • Basking Ridge, New Jersey
      • +6 more
      Jul 1, 2022

      BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

      Recruiting
      • BRAF NP_004324.2:p.V600E
      • +2 more
      • Duarte, California
      • +1 more
      Jan 19, 2023

      Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)

      Recruiting
      • Advanced Solid Tumor
      • BRAF V600 Mutation
      • San Francisco, California
      • +3 more
      Dec 30, 2022

      Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

      Recruiting
      • Cancer
      • +6 more
      • Indianapolis, Indiana
        Indiana University Hospital / IU Simon Cancer Center
      Jan 12, 2023

      Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

      Recruiting
      • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
      • +2 more
      • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
      • Chicago, Illinois
        Northwestern University
      Nov 16, 2022

      Melanoma Trial in Beijing (HL-085, Vemurafenib)

      Recruiting
      • Melanoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Apr 10, 2022

      Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

      Completed
      • Melanoma
      • +3 more
      • Binimetinib Oral Tablet
      • Rennes, France
        Biotrial
      Mar 31, 2023

      NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +5 more
      • Toripalimab
      • +3 more
      • Guanzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong Provincial People's H
      Apr 4, 2023

      Advanced Melanoma Trial in China (HLX208)

      Recruiting
      • Advanced Melanoma
      • Peking, Beijing, China
      • +6 more
      May 1, 2022